Sun Pharma faces lawsuit for allegedly violating patents
Despite legal struggles, investors’ confidence remains strong in the pharma giant.
25 July, 2024•2 min
0
25 July, 2024•2 min
0
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
$99 for one year
SUBSCRIBE
Already have an account? Sign In
Not ready to subscribe? Sign up for a free account
We value our free readers. Read 100+ stories every year.
More in Business
Business
Al-Futtaim, Cenomi Retail and understanding their landmark deal
The Emirati conglomerate has decided to aid the faltering Saudi firm, in what looks like one of the biggest retail alliances the two economies have seen in a long time.
You may also like
Internet
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
Internet
Why is Swiggy catching flak for its latest quick-delivery promise?
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.
Business
Natco just can’t kick its high-risk, high-gain game plan
CEO Rajeev Nannapaneni’s oft-used strategy of mounting patent challenges in the US got the pharma company its latest blockbuster Revlimid. But what after sales fall off a cliff?